New hope for older leukemia patients: gentler transplant tested
NCT ID NCT03232268
Summary
This study tested the safety of a new, gentler transplant method for older adults or those who cannot have a standard bone marrow transplant for leukemia or related blood cancers. The approach uses a small, mismatched donor transplant but skips the strong drugs that suppress the patient's immune system, hoping to avoid serious side effects. Researchers monitored 25 patients to see if this method could help control the cancer without causing dangerous immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Paoli Calmettes
Marseille, Bouches du Rhône, 13009, France
Conditions
Explore the condition pages connected to this study.